Fig. (2) Trend profile of visual acuity and foveal sensitivity after intravitreal injection of triamcinolone acetonide (IVTA) in BRVO patients with macular oedema. (A) In the Major group and the Macular group, visual acuity improved significantly from before IVTA to 3 and 6 months after IVTA (P=0.001 and P=0.022, respectively). There was no significant difference in the trend profile of visual acuity between the two groups (P=0.640). (B) In the Major group, the foveal sensitivity increased significantly from before IVTA to 3 and 6 months after IVTA (P<0.001). Although foveal sensitivity increased from before IVTA to 3 and 6 months after IVTA in Macular group as well, the changes were not significant (P=0.456). There was no significant difference in the trend profile of foveal sensitivity between the two groups (P=0.502).

Back to Article